Former Louisiana Attorney General Raises Shareholder Alert for AstraZeneca – Business Wire
Investors in securities of certain companies are facing a deadline in the securities class action lawsuit filed on behalf of investors who purchased or otherwise acquired the securities of the company during the class period. The lawsuit alleges violations of federal securities laws and focuses on whether the company issued material misrepresentations and failed to disclose information related to business operations and prospects.
If you suffered a loss in investments in this company, you have until the deadline to request that the court appoint you as lead plaintiff. A lead plaintiff is a representative party that acts on behalf of other class members in directing the litigation. Your ability to share in any recovery does not require that you serve as lead plaintiff.
To be a part of the case, you do not need to take any action at this time; you may retain counsel of your choice or take no action and remain an absent class member. If you wish to learn more about this securities class action or if you have any questions regarding this notice or your rights or interests, please reach out to the firm.
